page_head_bg

products

tofacitinib intermedia 1,4-Chloro-7-p-toluenesulfonyl-7H pyrrolo [2,3-d] pyrimidine CAS No.

Description:

Formulae hypotheticae:C13H10ClN3O2S
Pondus hypotheticum:307.755


Product Detail

Product Tags

Descriptio

Hujus intermedii formula hypothetica est C13H10ClN3O2S, ejusque pondus hypotheticum 307.755.Eius definitio hypothetica structura efficit efficientem ac puritatem efficiens tofacitinib.Ideo tofacitinib media 1,4-chloro-7-p-toluenesulfonyl-7H pyrrolo[2,3-d]pyrimidine momenti est in pharmaceutica industria ad efficacem curationem autoimmunerum morborum praestandam.

Producti nostri efficiuntur utentes processus artis status-of-artis ut summa qualitas et constantia curet.Magnitudinem tenemus habere intermedia certa et pura in productione pharmaceutica, quam ob rem committitur ut diligentissima signa in processu fabricando conservare.Nostra tofacitinib intermedia 1,4-chloro-7-p-toluenesulfonyl-7H pyrrolo[2,3-d]pyrimidine durissimam puritatem, stabilitatem ac salutem experitur ut clientibus nostris confideremus in fide magnae scalae synthesis tofacitinib.

Elige Us

JDK facilities productio primae classis et armorum administratio Qualitas habet, quod stabilitatem API intermediis confirmat.Professional team assure R&D producti.Contra utrumque, CMO & CDMO in foro domestico et internationali quaerimus.


  • Priora:
  • Deinde: